Compare Cigna Corp (CI) vs Chevron Corp (CVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Chevron Corp — how do they compare? Cigna Corp trades at $299.11 (market cap $80.25B), while Chevron Corp trades at $181.92 (market cap $361.99B). The key difference: Chevron Corp is far larger — about 4.5× Cigna Corp's market cap, and Chevron Corp pays the higher dividend (3.92%). Which is the better fit depends on your goals.
| CI | CVX | |
|---|---|---|
Market Cap | $80.25B | $361.99B |
Sector | Health | Energy |
52-Week High | $311.00 | $211.14 |
52-Week Low | $244.41 | $146.72 |
Enterprise Value | $103.35B | $402.09B |
Dividend Yield | 2.06% | 3.92% |
Volume | — | 9,807,834 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
CVX trades at $181.77, up 3.04% today, with a bullish technical signal and strong analyst consensus. Recent earnings have consistently beaten estimates, though revenue and net income have declined year-over-year. The company maintains solid cash flow from operations and recently announced a $13.8 billion investment in Argentina's Vaca Muerta shale play, signaling growth commitment. High oil prices and geopolitical tensions are key near-term catalysts.
Outlook remains positive given Wall Street's $207.56 price target and 62% buy ratings, but risks include declining profit margins, volatile oil prices, and execution challenges on new projects. The stock offers value through dividends and strategic expansion, yet investors face headwinds from macroeconomic uncertainty and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →
